Study to Investigate Long-term Pulmonary and Extrapulmonary Effects of COVID-19

Insel Gruppe AG, University Hospital Bern

Status: Completed

Conditions: COVID-19

Treatments: Other: COVID-19

Study type: Observational

Funder types: Other

Identifiers

NCT04581135

2020-00799

Details and patient eligibility

About

Prospective Observational Swiss Cohort Study to Investigate Long-term Pulmonary and Extrapulmonary Effects of COVID-19.

Full description

COVID-19 is a coronavirus induced viral pneumonia leading to Acute Respiratory Distress Syndrome. Previous coronavirus infections (SARS and MERS) led to pulmonary fibrosis in up to 30%. Prospective evaluation of lung abnormalities and pulmonary fibrosis after COVID-19 infection is crucial as novel treatments against lung fibrosis of different etiologies are available. No data on pulmonary longterm effects in COVID-19 survivors are currently available. The nation-wide Swiss COVID-19 lung group establishes a meticulously characterized prospective cohort study on pulmonary long-term sequela of patients living in Switzerland.

Enrollment: 620 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Signed written informed consent.
• All adult patients with COVID-19 over 18 years.

Exclusion criteria

• Severe mental or physical disability precluding informed consent or compliance with the protocol for prospective data collection.
• Pregnancy.

Trial design

620 participants in 1 patient group

COVID-19 Lung

Description:

COVID-19 survivors in Switzerland

Treatment:

Other: COVID-19